Professional Device · Needle-Free Protocol

Deliver Actives Beyond
the Skin Barrier

Precision Sonic Dermabrasion + Active Vehiculation

Fuse·X combines controlled mechanical dermabrasion with sonic vehiculation to transiently disrupt the stratum corneum, enabling subdermal delivery of Longevha and Reversha actives — with zero needles, zero downtime.

The Clinical Challenge

The Skin Barrier is Working Against You

The stratum corneum — the outermost layer of skin — is a formidable barrier. Up to 90% of topically applied actives never reach the viable dermis. High-value compounds like polynucleotides, growth factors, and peptides are simply too large to diffuse through intact skin.

Conventional topical application wastes your serum, your patient’s time, and your practice’s ROI. Fuse·X changes this equation — permanently.

Stratum Corneum — primary barrier (10–20µm)
Epidermis — viable layers
Basal Layer
Dermis — target zone for Longevha / Reversha
Subcutaneous — deep vascular zone 
Fuse·X transiently opens a 10–15 min absorption window at the stratum corneum

How Fuse·X Works

Three Mechanisms. One Protocol.

01

Sonic Dermabrasion

High-frequency vibration combined with precision-tip mechanical abrasion selectively removes the stratum corneum, creating a transient window for active delivery without disrupting deeper epidermal integrity.

Mechanical + Sonic Energy

Controlled Depth

02

Active Vehiculation

Immediately following dermabrasion, sonic energy drives Longevha and Reversha actives through the disrupted barrier via sonophoresis — a proven physical enhancement mechanism for subdermal delivery.

Sonophoresis

Subdermal Penetration

03

Dual LED Biomodulation

Integrated red and blue LED wavelengths support post-abrasion skin response, stimulate fibroblast activity, and enhance the local microenvironment for regenerative compound uptake.

Red 630nm

Blue 415nm

Concurrent Delivery

Exclusive EvoSkin Compounds

Engineered for Fuse·X Delivery

Longevha and Reversha are proprietary EvoSkin formulations developed specifically for sonic vehiculation. Their molecular architecture is optimized for post-abrasion transcutaneous delivery — maximizing bioavailability at the target depth.

L

EvoSkin Compound · Rejuvenation

Longevha

Advanced longevity-focused formulation for deep dermal rejuvenation. Delivers targeted regenerative signaling via the Fuse·X vehiculation protocol.

R

EvoSkin Compound · Reversal

Reversha

Targeted reversal protocol formulation addressing photoaging, textural irregularity, and inflammatory skin changes at the dermal level.

Unlike generic serums applied to intact skin, Longevha and Reversha are formulated with viscosity, pH, and molecular weight profiles matched to Fuse·X cartridge specifications — ensuring consistent, reproducible delivery with every treatment. The device-compound system creates a closed therapeutic loop that elevates your practice’s clinical standards.

Clinical & Business Advantages

Why Practices Choose Fuse·X

Maximized Serum ROI

Every drop of Longevha or Reversha reaches the target depth. Post-dermabrasion delivery efficiency dramatically reduces waste vs. standard topical application.

Zero Needle Protocols

Offer your needle-averse patients the same regenerative compounds without injection anxiety. No anaesthetic, no prep time, no sharps disposal.

No Downtime

Patients return to daily activity immediately. Lunch-break treatments become your highest-satisfaction SKU. Repeat visit rates increase significantly.

Add-On Revenue Stream

Integrate Fuse·X as a standalone treatment or enhance existing protocols — PRP, exosomes, PDRN. Each session generates compound repurchase revenue.

Protocol Training Included

EvoSkin provides certified hands-on training for your entire team. Guarino Academy CME-eligible modules available for physician-level certification.

Recurring Revenue Model

Single-use cartridges and compound bundles create predictable monthly revenue beyond the device investment. Average practice sees consumable revenue within 30 days.

Standard Treatment Protocol

Four Steps to Optimal Delivery

1

Cleanse & Prep

Standard skin prep. No topical anaesthetic required. Patient comfort throughout.

2

Sonic Dermabrasion

30–60 sec/zone. Controlled removal of stratum corneum. Transient barrier disruption confirmed.

3

Active Vehiculation

Longevha or Reversha applied immediately. Sonic energy drives penetration to target depth.

4

LED Biomodulation

2–4 min concurrent LED exposure. Patient discharged. No aftercare restrictions.

Competitive Positioning

Professional Technology at an Accessible Price

Fuse·X delivers equivalent core sonic dermabrasion and vehiculation performance — purpose-built for Longevha and Reversha delivery — at the most accessible professional price point in the market.

Feature Standard Fuse·X by EvoSkin
Sonic Dermabrasion ✓ Included ✓ Included
Needle-Free Vehiculation ✓ Included ✓ Included
Dual LED (Red + Blue) ✓ Included ✓ Included
Proprietary Companion Compounds ✕ Third-party only ✓ Longevha + Reversha
CME-Eligible Training ✕ Not available ✓ Guarino Academy
Entry Device Price $2,495 $1,495
Launch Bundle Available ✓ Device + 10 cartridges FREE

Investment Options

Simple, Transparent Pricing

Device Only
$1,495
One-time device investment
  • Fuse·X device
  • 5 starter cartridges
  • Standard onboarding
  • 12-month warranty
Get Started →
Multi-Unit / Practice
Custom
2+ devices · Volume pricing
  • Volume device pricing
  • Dedicated account manager
  • On-site team training
  • Co-branded marketing kit
  • Compound supply agreement
Contact Us →
Launch Offer: Device + 10 Cartridges, Free
For the first 90 days only — receive your Fuse·X device and 10 starter cartridges at no charge with the purchase of three Longevha/Reversha bundles.
Limited to first 90 days · While stock lasts
Claim Launch Offer →